http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3327007-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98e69150d30947a2451a43981d5af7d8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 |
| filingDate | 2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da6e3cd6c9c7f7364c9e75dccee98337 |
| publicationDate | 2018-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-3327007-A1 |
| titleOfInvention | Orbit azine-fumarate, hydrate, crystal form and preparation method therefor |
| abstract | The invention relates to the field of pharmaceutical chemistry, particularly relates to an orbit azine-fumarate, a hydrate, a crystal form, and a preparation method therefor. Specifically, in the invention, different crystal forms of orbit azine-fumarate, an orbit azine-fumarate hydrate and a crystal form thereof, and an amorphous form of orbit azine-fumarate are prepared by adjusting the ratio of orbit azine and fumaric acid and using different crystallization methods. The invention makes it possible to provide an orbit azine-fumarate which has a higher pharmaceutical effect, is easier to be prepared, and has a better storage stability. |
| priorityDate | 2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.